Muralidhar Mallem

Statistics

Publications

Citations

478

H-Index

Active since

2008

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Muralidhar Mallem is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, biotechnology, and glycosylation engineering.

Publications per year

2008–2014

Publications

Production of monoclonal antibodies by glycoengineered Pichia pastoris

Thomas I. Potgieter, Michael Cukan, J. E. Drummond et al. · Journal of Biotechnology · 2008 · 162 citations

Pharmacy, Biochemistry, Biotechnology +14

Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study

Ningyan Zhang, Calin Dan Dumitru, Nga Rewa Houston Cummings et al. · mAbs · 2011 · 94 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17

Antibody expression kinetics in glycoengineered <i>Pichia pastoris</i>

Thomas I. Potgieter, Sean D. Kersey, Muralidhar Mallem et al. · Biotechnology and Bioengineering · 2010 · 62 citations

Life Sciences, Biotechnology, Microbiology +16

Improved production of monoclonal antibodies through oxygen-limited cultivation of glycoengineered yeast

Marina Berdichevsky, Marc d′Anjou, Muralidhar Mallem et al. · Journal of Biotechnology · 2011 · 40 citations

Life Sciences, Biotechnology, Molecular Biology +14

Optimization of erythropoietin production with controlled glycosylation-PEGylated erythropoietin produced in glycoengineered Pichia pastoris

Juergen H. Nett, Sujatha Gomathinayagam, Stephen R. Hamilton et al. · Journal of Biotechnology · 2011 · 39 citations

Life Sciences, Biotechnology, Pharmaceutical Biotechnology +16

1–5 of 8